会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 84. 发明授权
    • Encoder and decoder for an SEC-DED-S4ED rotational code
    • 用于SEC-DED-S4ED旋转码的编码器和解码器
    • US5856987A
    • 1999-01-05
    • US801617
    • 1997-02-18
    • Thomas J. Holman
    • Thomas J. Holman
    • H03M7/36H03M13/15H03M13/00
    • H03M13/151
    • A computer system employs a SEC-DED-S4ED rotational error control code (ECC) wherein all columns of H matrix are linearly independent and have an odd weight, and are arranged to allow detection of 4-bit byte errors. The ECC includes check bits arranged in a specific manner in designated columns of the matrix to permit detection and correction of single bit errors, as well as detection of double, triple and quadruple bit errors. The computer system employing the ECC also includes a data path having a variety of implementations; e.g., a single 72-bit path, two 36-bit paths, or a single 36-bit path.
    • 计算机系统采用SEC-DED-S4ED旋转误差控制码(ECC),其中H矩阵的所有列都是线性独立的并且具有奇数权重,并且被布置为允许检测4位字节错误。 ECC包括以特定方式布置在矩阵的指定列中的校验位,以允许检测和校正单个位错误,以及检测双重,三重和四重位错误。 采用ECC的计算机系统还包括具有各种实现的数据路径; 例如单个72位路径,两个36位路径或单个36位路径。
    • 86. 发明授权
    • Internal medical devices for delivery of therapeutic agent in conjunction with a source of electrical power
    • 用于与电力源一起递送治疗剂的内部医疗装置
    • US08538515B2
    • 2013-09-17
    • US12939363
    • 2010-11-04
    • Liliana AtanasoskaThomas J. HolmanJan WeberRobert WarnerScott Schewe
    • Liliana AtanasoskaThomas J. HolmanJan WeberRobert WarnerScott Schewe
    • A61N1/30
    • A61N1/325A61N1/05A61N1/306A61N1/327
    • The invention generally relates to internal (e.g., implantable, insertable, etc.) drug delivery devices which contain the following: (a) one or more sources of one or more therapeutic agents; (b) one or more first electrodes, (c) one or more second electrodes and (d) one or more power sources for applying voltages across the first and second electrodes. The power sources may be adapted, for example, to promote electrically assisted therapeutic agent delivery within a subject, including electroporation and/or iontophoresis. In one aspect of the invention, the first and second electrodes are adapted to have tissue of a subject positioned between them upon deployment of the medical device within the subject, such that an electric field may be generated, which is directed into the tissue. Furthermore, the therapeutic agent sources are adapted to introduce the therapeutic agents into the electric field. In another aspect, the therapeutic agent sources are polymeric regions that contain one or more types of ion-conductive polymers and one or more types of charged therapeutic agents. In yet another aspect, the therapeutic agent sources are polymeric regions that contain one or more types of electrically conductive polymers and one or more types of charged therapeutic agents.
    • 本发明一般涉及含有以下物质的内部(例如,可植入,可插入等)药物递送装置:(a)一种或多种一种或多种治疗剂来源; (b)一个或多个第一电极,(c)一个或多个第二电极和(d)用于在第一和第二电极上施加电压的一个或多个电源。 电源可以适应于例如促进受试者内的电辅助治疗剂递送,包括电穿孔和/或离子电渗疗法。 在本发明的一个方面中,第一和第二电极适于在医疗装置在受试者内展开时使被检体的组织位于它们之间,使得可以产生被引导到组织中的电场。 此外,治疗剂源适于将治疗剂引入电场。 另一方面,治疗剂来源是含有一种或多种类型的离子导电聚合物和一种或多种类型的带电治疗剂的聚合物区域。 在另一方面,治疗剂来源是含有一种或多种类型的导电聚合物和一种或多种类型的带电治疗剂的聚合物区域。